<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="81586">
  <stage>Registered</stage>
  <submitdate>5/09/2006</submitdate>
  <approvaldate>11/09/2006</approvaldate>
  <actrnumber>ACTRN12606000396527</actrnumber>
  <trial_identification>
    <studytitle>Hepatitis B immunity and response to a booster dose of hepatitis B vaccine in Indigenous children who recieved hepatitis B vaccines in infancy</studytitle>
    <scientifictitle>Hepatitis B immunity and response to a booster dose of hepatitis B vaccine in Indigenous children who recieved hepatitis B vaccines in infancy</scientifictitle>
    <utrn />
    <trialacronym>Long term hepatitis B immunity</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>Hepatitis B immunity in healthy subjects</healthcondition>
    <conditioncode>
      <conditioncode1>Inflammatory and Immune System</conditioncode1>
      <conditioncode2>Normal development and function of the immune system</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Adolescents with low immunity will be offered booster doses of the vaccine and have their immunity measured 2-4 weeks post vaccination.
HBVaxII 10microgram dose vaccine will be administered intramsucularly in this study
Study duration is 1 month approximately</interventions>
    <comparator>No comparator.</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Prevention</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Hepatitis B surface antibody measurement</outcome>
      <timepoint>At baseline and  2-4 weeks post vaccination</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Measurement of hepatitis B surface antigen</outcome>
      <timepoint>At baseline - prior to vaccination</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Enrolled in the Aboriginal Birth Cohort (ABC).</inclusivecriteria>
    <inclusiveminage>16</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>19</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Not enrolled in original Aboriginal Birth Cohort StudyAll participants have their hepatitis B serology measured at baselineBooster vaccination for only those whose HBsAb level &lt;10 IU/ml.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/04/2006</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>450</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Government body</primarysponsortype>
    <primarysponsorname>National Centre for Immunisation Research and Surveillance</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>NHMRC</fundingname>
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Charities/Societies/Foundations</sponsortype>
      <sponsorname>Menzies School of Health research</sponsorname>
      <sponsoraddress />
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Adolescent enrolled in the Aboriginal Birth Cohort Study will have their serology to hepatitis B measured. Adolescents who received hepatitis B vaccines in infancy and have low immunity will be offered booster doses of the vaccine and have their immunity measured 2-4 weeks post vaccination.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Menzies School of Health Research</ethicname>
      <ethicaddress />
      <ethicapprovaldate>2/06/2006</ethicapprovaldate>
      <hrec>06/05</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Nicholas Wood</name>
      <address>National Centre for Immunisation Research and Surveillance
Locked Bag 4001
The Children's Hospital at Westmead
Westmead NSW 2145</address>
      <phone>02 9845 1434</phone>
      <fax>02 9845 1418</fax>
      <email>nicholw3@chw.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Nicholas Wood</name>
      <address>National Centre for Immunisation Research and Surveillance
Locked Bag 4001
The Children's Hospital at Westmead
Westmead NSW 2145</address>
      <phone>02 9845 1434</phone>
      <fax>02 9845 1418</fax>
      <email>nicholw3@chw.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>